High Doses of 4-Aminopyridine Improve Functionality in Chronic Complete Spinal Cord Injury Patients with MRI Evidence of Cord Continuity

Michaelis, 1969, International inquiry on neurological terminology and prognosis in paraplegia and tetraplegia, Paraplegia, 7, 1, 10.1038/sc.1969.2 Ducker, 1983, Recovery from spinal cord injury, Clin Neurosurg, 30, 495, 10.1093/neurosurgery/30.CN_suppl_1.495 Meinecke, 1985, Some thoughts about neurological recovery in spinal cord injuries: a philosophical review, Paraplegia, 23, 78, 10.1038/sc.1985.14 Piepmeier, 1988, Late neurological changes following traumatic spinal cord injury, J Neurosurg, 69, 399, 10.3171/jns.1988.69.3.0399 Waters, 1993, Motor and sensory recovery following complete tetraplegia, Arch Phys Med Rehabil, 74, 242 Schonherr, 1999, Functional outcome of patients with spinal cord injury: rehabilitation outcome study, Clin Rehabil, 13, 457, 10.1191/026921599666105472 Smith, 2000, Corticospinal function studied over time following incomplete spinal cord injury, Spinal Cord, 38, 292, 10.1038/sj.sc.3100994 Kirshblum, 2004, Late neurological recovery after traumatic spinal cord injury, Arch Phys Med Rehabil, 85, 1811, 10.1016/j.apmr.2004.03.015 Ditunno, 1992, Motor recovery of upper extremities in traumatic quadriplegia: a multicenter study, Arch Phys Med Rehabil, 73, 431 McDonald, 2002, Late recovery following spinal cord injury. Case report and review of the literature, J Neurosurg (Spine 2), 97, 252, 10.3171/spi.2002.97.2.0252 Bunge, 1993, Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination, Adv Neurol, 59, 75 Melinek, 1994, Calcitonin gene-related peptide (CGRP)-like immunoreactivity in motoneurons of the human spinal cord following injury, J Neurotrauma, 11, 63, 10.1089/neu.1994.11.63 Kakulas, 1999, A review of the neuropathology of human spinal cord injury with emphasis of special features, J Spinal Cord Med, 22, 119, 10.1080/10790268.1999.11719557 Kakulas, 1999, The applied neuropathology of human spinal cord injury, Spinal Cord, 37, 79, 10.1038/sj.sc.3100807 Blight, 1983, Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling, Neuroscience, 10, 521, 10.1016/0306-4522(83)90150-1 Salgado-Ceballos, 1998, Spontaneous long-term remyelination after traumatic spinal cord injury in rats, Brain Res, 782, 126, 10.1016/S0006-8993(97)01252-3 Guest, 2005, Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury, Exp Neurol, 192, 384, 10.1016/j.expneurol.2004.11.033 Sherratt, 1980, Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibers, Nature, 283, 570, 10.1038/283570a0 Blight, 1989, Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury, Brain Res Bull, 22, 47, 10.1016/0361-9230(89)90126-3 Blight, 1991, The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial, J Neurotrauma, 8, 103, 10.1089/neu.1991.8.103 Shi, 1997, Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine, Exp Neurol, 148, 495, 10.1006/exnr.1997.6706 Gruner, 1999, 4-Aminopyridine enhances motor evoked potentials following graded spinal cord compression injury in rats, Brain Res, 816, 446, 10.1016/S0006-8993(98)01184-6 Hansebout, 1993, 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients, J Neurotrauma, 10, 1, 10.1089/neu.1993.10.1 Hayes, 1993, Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury, Paraplegia, 31, 216, 10.1038/sc.1993.40 Hayes, 1994, 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury, J Neurotrauma, 11, 433, 10.1089/neu.1994.11.433 Segal, 1999, Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial, Pharmacotherapy, 19, 713, 10.1592/phco.19.9.713.31540 Wang, 1996, A clinical magnetic resonance imaging study of the traumatized spinal cord more than 20 years following injury, Paraplegia, 34, 65, 10.1038/sc.1996.13 Bodley, 2002, Imaging in chronic spinal cord injury indications and benefits, Eur J Radiol, 42, 135, 10.1016/S0720-048X(02)00046-3 Grijalva, 2003, Efficacy and safety of 4-aminopyridine in chronic spinal cord injured patients: randomized, double blind controlled clinical trial, Pharmacotherapy, 23, 823, 10.1592/phco.23.7.823.32731 Maynard, 1997, International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association, Spinal Cord, 35, 266, 10.1038/sj.sc.3100432 Catz, 1997, SCIM-spinal cord independence measure: a new disability scale for patients with spinal cord lesions, Spinal Cord, 35, 850, 10.1038/sj.sc.3100504 Mauguiere, 1999, Somatosensory evoked potentials, 79 Wolfe, 2001, Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury: a double-blinded, placebo-controlled crossover trial, J Neurotrauma, 18, 757, 10.1089/089771501316919120 Bunge, 1997, Observations on the pathology of several types of human spinal cord injury, with emphasis on the astrocyte response to penetrating injuries, Adv Neurol, 72, 305 Potter, 1998, Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury, J Neurotrauma, 15, 837, 10.1089/neu.1998.15.837 Goodman, 1997, Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo controlled, dose-ranging study, Mult Scler, 13, 357, 10.1177/1352458506069538 Goodman, 2008, Dose comparison trial of sustained-release fampridine in multiple sclerosis, Neurology, 71, 1134, 10.1212/01.wnl.0000326213.89576.0e Hayes, 2007, Fampridine-SR for multiple sclerosis and spinal cord injury, Expert Rev Neurother, 7, 453, 10.1586/14737175.7.5.453